Physician

Ross Edward Vogelgesang, MD

According to 2025 Medicare claims, Ross Vogelgesang, MD (NPI: 1518919505) practices anesthesiology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is VOGELGESANG, PLLC (NPI: 1275585283; TIN: 134311436) and primary practice location at 98502-8509. Vogelgesang is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Vogelgesang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 392 traditional Medicare patients, billed 2,211 HCPCS/CPT codes, and received $133,296 in Medicare payments. The top billing code was 64635 (Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint). Part D data shows 782 prescription claims across 139 beneficiaries totaling $34,004 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). 2022 DME data shows 11 claims. Open Payments data shows 14 records totaling $4,709. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $498,716 and ending at $133,296. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $246,440 to $34,004. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $6,741 to $3,703.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	466	5,486	$498,716
2016	419	3,855	$306,233
2017	395	3,275	$259,992
2018	371	2,850	$213,713
2019	388	2,813	$196,150
2020	417	4,014	$283,906
2021	450	5,203	$416,622
2022	424	3,702	$332,889
2023	437	2,911	$248,997
2024	392	2,211	$133,296

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	238	2,809	$246,440
2016	293	3,106	$348,151
2017	245	2,165	$277,409
2018	232	2,227	$263,514
2019	273	2,192	$237,638
2020	248	1,586	$108,893
2021	216	957	$59,109
2022	168	560	$24,192
2023	176	648	$23,930
2024	139	782	$34,004

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$1,026
2016	44	118	$3,989
2017	N/R	54	$1,216
2018	N/R	24	$525
2019	42	42	$12,971
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	11	11	$8,006
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64635	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint	18	20	$219
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	75	$89
80307	Testing for presence of drug, by chemistry analyzers	361	1,553	$57
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	35	39	$9
J1100	Injection, dexamethasone sodium phosphate, 1 mg	31	179	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	52	1,548	$14,446
Pregabalin	Pregabalin	167	6,906	$7,425
Duloxetine Hcl	Duloxetine Hcl	105	3,870	$968
Gabapentin	Gabapentin	56	2,045	$812
Baclofen	Baclofen	45	1,830	$753

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$4,709	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ross Edward Vogelgesang, MD?

Tedicare shows public-source Medicare data for Ross Edward Vogelgesang, MD (NPI 1518919505), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ross Edward Vogelgesang, MD have ACO affiliation data?

Ross Edward Vogelgesang, MD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Ross Edward Vogelgesang, MD?

Ross Edward Vogelgesang, MD is linked to VOGELGESANG, PLLC (billing NPI 1275585283) in the available physician profile data.

Does Ross Edward Vogelgesang, MD have Open Payments data?

Ross Edward Vogelgesang, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.